Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:PBSNYSEARCA:QPTCVE:RVVCVE:SVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePBSInvesco Next Gen Media and Gaming ETF$60.42+1.3%$54.59$30.95▼$40.10$54.98M1.225,287 shs5,108 shsQPTAdvisorShares Q Portfolio Blended Allocation ETF$19.10+0.1%$19.10$18.63▼$27.54$1.91MN/A1,912 shs19,400 shsRVVRevive TherapeuticsC$0.08+14.3%C$0.08C$0.07▼C$0.25C$5.79MN/A93,085 shs212,852 shsSVSSolarvest BioEnergyC$0.03C$0.02C$0.01▼C$0.14C$1.52M1.577,594 shs3,159 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePBSInvesco Next Gen Media and Gaming ETF+1.31%+4.17%+10.54%+20.32%+27.30%QPTAdvisorShares Q Portfolio Blended Allocation ETF0.00%0.00%0.00%0.00%0.00%RVVRevive Therapeutics0.00%0.00%0.00%0.00%0.00%SVSSolarvest BioEnergy0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPBSInvesco Next Gen Media and Gaming ETFN/AN/AN/AN/AN/AN/AN/AN/AQPTAdvisorShares Q Portfolio Blended Allocation ETFN/AN/AN/AN/AN/AN/AN/AN/ARVVRevive TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePBSInvesco Next Gen Media and Gaming ETF 2.71Moderate Buy$60.42N/AQPTAdvisorShares Q Portfolio Blended Allocation ETF 0.00N/AN/AN/ARVVRevive Therapeutics 0.00N/AN/AN/ASVSSolarvest BioEnergy 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPBSInvesco Next Gen Media and Gaming ETFN/AN/AN/AN/AN/AN/AQPTAdvisorShares Q Portfolio Blended Allocation ETFN/AN/AN/AN/AN/AN/ARVVRevive TherapeuticsN/AN/AC$0.03 per share3.18C$0.02 per shareN/ASVSSolarvest BioEnergyC$740.002,052.70C$0.00 per share55.00C($0.10) per share-0.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePBSInvesco Next Gen Media and Gaming ETFN/AN/A30.67∞N/AN/AN/AN/AN/AQPTAdvisorShares Q Portfolio Blended Allocation ETFN/AN/A0.00∞N/AN/AN/AN/AN/ARVVRevive TherapeuticsN/A-C$0.02N/A∞N/AN/AN/AN/AN/ASVSSolarvest BioEnergy-C$2.26M-C$0.04N/A∞N/AN/AN/A-143.12%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPBSInvesco Next Gen Media and Gaming ETF$1.011.67%N/AN/AN/AQPTAdvisorShares Q Portfolio Blended Allocation ETF$0.080.42%N/AN/AN/ARVVRevive TherapeuticsN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPBSInvesco Next Gen Media and Gaming ETFN/AN/AN/AQPTAdvisorShares Q Portfolio Blended Allocation ETFN/AN/AN/ARVVRevive TherapeuticsN/A6.146.03SVSSolarvest BioEnergyN/AN/A0.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPBSInvesco Next Gen Media and Gaming ETFN/AQPTAdvisorShares Q Portfolio Blended Allocation ETFN/ARVVRevive TherapeuticsN/ASVSSolarvest BioEnergyN/AInsider OwnershipCompanyInsider OwnershipPBSInvesco Next Gen Media and Gaming ETFN/AQPTAdvisorShares Q Portfolio Blended Allocation ETFN/ARVVRevive TherapeuticsN/ASVSSolarvest BioEnergy15.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePBSInvesco Next Gen Media and Gaming ETFN/A910,000N/ANot OptionableQPTAdvisorShares Q Portfolio Blended Allocation ETFN/A100,000N/ANot OptionableRVVRevive TherapeuticsN/A72.41 millionN/ANot OptionableSVSSolarvest BioEnergyN/A60.76 millionN/ANot OptionableSVS, QPT, RVV, and PBS HeadlinesRecent News About These CompaniesSolarvest expands Asean footprint with Brunei’s solar power dealJune 17, 2025 | thestar.com.myTSolarvest to build 30MW solar project, Brunei’s largest PV plant to dateJune 16, 2025 | pv-tech.orgPSolarvest continues to make hay as the sun shinesJune 10, 2025 | thestar.com.myTA Look At The Intrinsic Value Of Solarvest Holdings Berhad (KLSE:SLVEST)May 27, 2025 | finance.yahoo.comSolarvest order book to surpass RM2bil in FY26May 21, 2025 | thestar.com.myTSolarvest optimistic orderbook to surpass RM2bil in FY26May 21, 2025 | thestar.com.myTMIDA Facilitates RM142 Mln Energy Partnership Between Solarvest, HSS & Shizen At Osaka ExpoApril 17, 2025 | bernama.comBWhile private companies own 23% of Solarvest Holdings Berhad (KLSE:SLVEST), individual investors are its largest shareholders with 32% ownershipApril 16, 2025 | finance.yahoo.comSolarvest order book hits record RM1.4bilMarch 27, 2025 | thestar.com.myTSolarvest maintains sunny outlookMarch 27, 2025 | thestar.com.myTSolarvest To Be Prime Beneficiary Of Large-scale Solar Contracts - HLIBMarch 27, 2025 | bernama.comBSolarvest unit wins RM103mil EPCC contractMarch 27, 2025 | thestar.com.myTSolarvest unit secures RM103.08mil EPCC contract for solar PV facility in Pulau PinangMarch 26, 2025 | thestar.com.myTUpbeat outlook for Solarvest on LSS5 plan shortlistMarch 21, 2025 | thestar.com.myTSolarvest subsidiary signs PPA for 60MWac solar PV facilityMarch 19, 2025 | thestar.com.myTSolarvest In Good Position To Capitalise On Malaysia RE Sector Opportunities - Maybank IBMarch 18, 2025 | bernama.comBSolarvest bags EPCC deal valued at RM401milMarch 18, 2025 | thestar.com.myTSolarvest unit bags RM401mil EPCC works project under LSS5March 17, 2025 | thestar.com.myTSolarvest’s prospects brighten with new projectsFebruary 26, 2025 | thestar.com.myTSolarvest net profit jumps 35% in 3Q25February 20, 2025 | thestar.com.myTMedia Sentiment Over TimeSVS, QPT, RVV, and PBS Company DescriptionsInvesco Next Gen Media and Gaming ETF NYSEARCA:PBS$60.42 +0.78 (+1.31%) As of 06/26/2025PowerShares Dynamic Media Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Media Intellidex Index (the Index). The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States media companies. These are companies that are principally engaged in the development, production, sale and distribution of goods or services used in the media industry. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.AdvisorShares Q Portfolio Blended Allocation ETF NYSEARCA:QPT$19.10 +0.01 (+0.05%) As of 10/28/2022Revive Therapeutics CVE:RVVC$0.08 +0.01 (+14.29%) As of 07/22/2019Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.Solarvest BioEnergy CVE:SVSC$0.02 0.00 (0.00%) As of 09/5/2023Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Broadcom’s Big VMware Update: A Threat to Public Cloud Giants? Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.